Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 2311 AL 2325

From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein

Heras-Garvin A, Stefanova N.

Front Synaptic Neurosci. 2020 Sep 21;12:584536. doi: 10.3389/fnsyn.2020.584536. eCollection 2020.

Manganese, a Likely Cause of 'Parkinson's in Cirrhosis', a Unique Clinical Entity of Acquired Hepatocerebral Degeneration

Mehkari Z, Mohammed L, Javed M, Althwanay A, Ahsan F, Oliveri F, Goud HK, Rutkofsky IH.

Cureus. 2020 Sep 14;12(9):e10448. doi: 10.7759/cureus.10448.

Natural Compounds and Autophagy: Allies Against Neurodegeneration

Stacchiotti A, Corsetti G.

Front Cell Dev Biol. 2020 Sep 22;8:555409. doi: 10.3389/fcell.2020.555409. eCollection 2020.

A case study of foliglurax, the first clinical mGluR4 PAM for symptomatic treatment of Parkinson's disease: translational gaps or a failing industry innovation model?

Doller D, Bespalov A, Miller R, Pietraszek M, Kalinichev M.

Expert Opin Investig Drugs. 2020 Dec;29(12):1323-1338. doi: 10.1080/13543784.2020.1839047. Epub 2020 Nov 11.

Relationship between Sarcopenia and Swallowing Capacity in Community-Dwelling Older Women

Suzuki M, Kimura Y, Otobe Y, Kikuchi T, Masuda H, Taguchi R, Tanaka S, Narita Y, Shino S, Kusumi H, Yamada M.

Gerontology. 2020;66(6):549-552. doi: 10.1159/000511359. Epub 2020 Oct 19.

Management of Young Athletes with Asymptomatic Preexcitation-A Review of the Literature

Książczyk TM, Pietrzak R, Werner B.

Diagnostics (Basel). 2020 Oct 15;10(10):824. doi: 10.3390/diagnostics10100824.

Applications of Exosomes in Targeted Drug Delivery for the Treatment of Parkinson's Disease: A Review of Recent Advances and Clinical Challenges

Kumar B, Pandey M, Fayaz F, Izneid TA, Pottoo FH, Manchanda S, Sharma A, Sahoo PK.

Curr Top Med Chem. 2020;20(30):2777-2788. doi: 10.2174/1568026620666201019112557.

Effect of rTMS on Parkinson's cognitive function: a systematic review and meta-analysis

Jiang Y, Guo Z, McClure MA, He L, Mu Q.

BMC Neurol. 2020 Oct 19;20(1):377. doi: 10.1186/s12883-020-01953-4.

Allosteric inhibition of LRRK2, where are we now

Soliman A, Cankara FN, Kortholt A.

Biochem Soc Trans. 2020 Oct 30;48(5):2185-2194. doi: 10.1042/BST20200424.

Performance of Force-Field- and Machine Learning-Based Scoring Functions in Ranking MAO-B Protein-Inhibitor Complexes in Relevance to Developing Parkinson's Therapeutics

Murugan NA, Muvva C, Jeyarajpandian C, Jeyakanthan J, Subramanian V.

Int J Mol Sci. 2020 Oct 16;21(20):7648. doi: 10.3390/ijms21207648.

Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson's Disease

Prasad EM, Hung SY.

Antioxidants (Basel). 2020 Oct 16;9(10):1007. doi: 10.3390/antiox9101007.

Extradural Motor Cortex Stimulation might improve episodic and working memory in patients with Parkinson's disease

Piano C, Ciavarro M, Bove F, Di Giuda D, Cocciolillo F, Bentivoglio AR, Cioni B, Tufo T, Calabresi P, Daniele A.

NPJ Parkinsons Dis. 2020 Sep 28;6:26. doi: 10.1038/s41531-020-00129-8. eCollection 2020.

[Modern view on normal-tension glaucoma]

Petrov SY.

Vestn Oftalmol. 2020;136(6):57-64. doi: 10.17116/oftalma202013606157.

Role of homocysteine in the development and progression of Parkinson's disease

Fan X, Zhang L, Li H, Chen G, Qi G, Ma X, Jin Y.

Ann Clin Transl Neurol. 2020 Nov;7(11):2332-2338. doi: 10.1002/acn3.51227. Epub 2020 Oct 21.

Age-Related Diseases and Driving Safety

Falkenstein M, Karthaus M, Brüne-Cohrs U.

Geriatrics (Basel). 2020 Oct 19;5(4):80. doi: 10.3390/geriatrics5040080.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias